These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7015558)

  • 1. Assay methodology for urokinase: its use in assessing the composition of mixtures of high- and low-molecular weight urokinase.
    Philo RD; Gaffney PJ
    Thromb Res; 1981 Jan 1-15; 21(1-2):81-8. PubMed ID: 7015558
    [No Abstract]   [Full Text] [Related]  

  • 2. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The contamination with coagulative substance in urokinase preparation (author's transl)].
    Shiba T; Igarashi M; Hirose K; Takeuchi S; Awazu S; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):537-40. PubMed ID: 495012
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine.
    Husain SS; Gurewich V; Lipinski B
    Arch Biochem Biophys; 1983 Jan; 220(1):31-8. PubMed ID: 6338833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher fibrin-binding and thrombolytic properties of single polypeptide chain--high molecular weight urokinase.
    Sumi H; Maruyama M; Matsuo O; Mihara H; Toki N
    Thromb Haemost; 1982 Jun; 47(3):297. PubMed ID: 7051412
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrin activatable urokinase (FA-UK): a latent form of UK found in urine related to a complex with an inhibitor/fibrin-interacting cofactor.
    Dwivedi C; Pannell R; Gurewich V
    Thromb Res; 1988 Jul; 51(2):197-208. PubMed ID: 3055414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase.
    Shibatani T; Kakimoto T; Chibata I
    Thromb Haemost; 1983 Apr; 49(2):91-5. PubMed ID: 6346574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on two active enzyme forms of human urinary urokinase. I. Purification by serial column chromatography and homogeneity analyses of molecular weight and isoelectric point.
    Miwa N; Takayanagi H; Suzuki A
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):463-71. PubMed ID: 7023709
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
    Kirchheimer JC; Resch I; Christ G; Wojta J; Binder BR
    Eur J Biochem; 1987 Jul; 166(2):393-7. PubMed ID: 3609016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of human urine urokinase by column chromatography on sawdust and some properties of the enzyme obtained.
    Kobayashi O; Matsui K; Minamiura N; Yamamoto T
    J Chromatogr; 1981 May; 210(1):180-5. PubMed ID: 7019226
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the biochemistry of urokinase.
    Ong EB; Soberano ME; Johnson AJ; Schoellmann G
    Thromb Haemost; 1977 Dec; 38(4):801-8. PubMed ID: 579688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on a plasminogen activating system in human milk: IV. Difference in the binding to fibrin between human milk plasminogen activator (mild activator) and urokinase (author's transl)].
    Horie N
    Nihon Ketsueki Gakkai Zasshi; 1979 Oct; 42(5):38-45. PubMed ID: 396753
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of plasminogen activation and hydrolysis of purified fibrinogen and fibrin by dextran 70.
    Carlin G; Bang NU
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):535-46. PubMed ID: 6160642
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of urokinase in the urine using thrombelastography and the fibrin-plate test].
    Stein G; Lindner M; Schultz C; Neumann W
    Z Gesamte Inn Med; 1974 Dec; 29(24):1027-30. PubMed ID: 4458319
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
    Marder VJ; Donahoe JF; Bell WR; Cranley JJ; Kwaan HC; Sashara AA; Barlow GH
    J Lab Clin Med; 1978 Nov; 92(5):721-9. PubMed ID: 712206
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
    Gurewich V; Pannell R
    Semin Thromb Hemost; 1987 Apr; 13(2):146-51. PubMed ID: 3114882
    [No Abstract]   [Full Text] [Related]  

  • 17. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.
    Samama M; Castel M; Matsuo O; Hoylaerts M; Lijnen HR
    Thromb Haemost; 1982 Feb; 47(1):36-40. PubMed ID: 7041325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase.
    Gilbert LC; Wachsman JT
    Biochim Biophys Acta; 1982 Jun; 704(3):450-60. PubMed ID: 7052133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
    Hua ZC; Chen XC; Dong C; Zhu DX
    Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.